714 filings
Page 3 of 36
PRE 14A
CDXC
Chromadex Corp
Preliminary proxy
19 Apr 23
4:07pm
8-K
CDXC
Chromadex Corp
17 Mar 23
Amendments to Articles of Incorporation or Bylaws
4:32pm
8-K
CDXC
Chromadex Corp
8 Mar 23
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2022 Results
4:02pm
10-K
2022 FY
CDXC
Chromadex Corp
Annual report
8 Mar 23
4:01pm
4
Brianna Gerber
17 Feb 23
ChromaDex / Brianna Gerber ownership change
5:09pm
4
Fried Robert N
17 Feb 23
ChromaDex / Robert N Fried ownership change
5:05pm
8-K
CDXC
Chromadex Corp
5 Jan 23
Departure of Directors or Certain Officers
9:29am
424B3
CDXC
Chromadex Corp
17 Nov 22
Prospectus supplement
4:03pm
EFFECT
CDXC
Chromadex Corp
17 Nov 22
Notice of effectiveness
12:15am
CORRESP
CDXC
Chromadex Corp
14 Nov 22
Correspondence with SEC
12:00am
UPLOAD
CDXC
Chromadex Corp
9 Nov 22
Letter from SEC
12:00am
S-3
CDXC
Chromadex Corp
Shelf registration
3 Nov 22
5:24pm
10-Q
2022 Q3
CDXC
Chromadex Corp
Quarterly report
2 Nov 22
4:04pm
8-K
CDXC
Chromadex Corp
2 Nov 22
ChromaDex Corporation Reports Third Quarter 2022 Financial Results
4:02pm
SC 13G
Societe des Produits Nestle S.A.
19 Oct 22
ChromaDex / Societe des Produits Nestle ownership change
3:22pm
D
CDXC
Chromadex Corp
14 Oct 22
$3.10 mm in equity, sold $3.10 mm, 3 investors
4:05pm
424B5
CDXC
Chromadex Corp
11 Oct 22
Prospectus supplement for primary offering
4:21pm
8-K
CDXC
Chromadex Corp
11 Oct 22
ChromaDex and Nestlé Health Science Announce New Niagen® Commercial Supply Agreement and $5 Million Investment
4:05pm
4
Fried Robert N
3 Oct 22
ChromaDex / Robert N Fried ownership change
8:17pm
4
Dvorak International Ltd
3 Oct 22
ChromaDex / Hoi Shuen Solina Holly Chau ownership change
8:34am